billHR9392Event Tuesday, June 23, 2026Analyzed

To amend title XVIII of the Social Security Act to require the inclusion of certain information in Medicare Advantage encounter data.

Neutral

Summary

HR9392 is a procedural bill requiring Medicare Advantage plans to include additional data in encounter submissions. It is in early legislative stages with no funding authorized. Market impact is minimal for major insurers like UNH, HUM, and ELV, as compliance costs are trivial relative to revenue.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HR9392 is a low-impact data reporting mandate for Medicare Advantage plans, not a funding bill.
  • 2.Major Medicare Advantage insurers (UNH, HUM, ELV) face minimal compliance costs relative to revenue.
  • 3.The bill is in early legislative stage with no significant market implications expected.

Market Implications

No real market data is available for this specific event. The bill's early status and lack of funding mean no structural change to MA industry economics. Share prices of UNH, HUM, and ELV are unlikely to move on this news. Focus on broader industry trends like Medicare Advantage enrollment and rate updates.

Full Analysis

HR9392, introduced by Rep. DeGette (D-CO) on June 23, 2026, amends the Social Security Act to mandate inclusion of specific information in Medicare Advantage (MA) encounter data. The bill has been referred to the House Ways and Means and Energy and Commerce Committees. No funding is authorized; it is a data-reporting requirement only. The legislative path is long: it must pass both committees, the full House, Senate, and be signed by the President. As an early-stage procedural bill, it carries no near-term financial impact. The primary effect would be increased operational costs for MA plans to update data systems, but for large public insurers like UnitedHealth Group (UNH), Humana (HUM), and Elevance Health (ELV), such costs are immaterial (likely <0.1% of annual revenue). Smaller, private MA plans may face a larger relative burden, but no publicly traded pure-play MA insurer exists. No convergence signals are present. The bill's slow progress and lack of funding ensure no immediate market reaction.

Intelligence Surface

Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures

Unconfirmed

No confirming evidence found yet from contracts, insider trades, or congressional activity

$$HUM● Neutral

What the bill does

Same mandate for Medicare Advantage encounter data reporting

Who must act

Medicare Advantage organizations including Humana

What happens

Compliance cost increase for data infrastructure; similar proportional impact as UNH

Stock impact

Humana has ~5M Medicare Advantage members; revenue impact negligible as costs are spread across large base

$$ELV● Neutral

What the bill does

Same mandate for Medicare Advantage encounter data reporting

Who must act

Medicare Advantage organizations including Elevance Health (Anthem)

What happens

Modest compliance cost for data system modifications

Stock impact

Elevance serves ~2M Medicare Advantage members; compliance burden is low relative to total revenue ($156B in 2025)

Key Legislators

Rep. DeGette, Diana [D-CO-1]

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderJun 3, 2026

Implementing Schedule Policy/Career in the Excepted Service

This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.

Exec OrderMay 29, 2026

Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries

This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.

Exec OrderApr 30, 2026

Promoting Efficiency, Accountability, and Performance in Federal Contracting

This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →